MIU
MYGN icon

Man Investments (UK)’s Myriad Genetics MYGN Stock Holding History

Man Investments (UK)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$272K Buy
6,987
+718
+11% +$26.7K 0.02% 660
2014
Q1 		$214K Buy
+6,269
New +$194K 0.02% 662
2013
Q4 		– Sell
-59,178
Closed -$1.39M – 660
2013
Q3 		$1.39M Buy
59,178
+48,725
+466% +$1.38M 0.19% 226
2013
Q2 		$281K Buy
+10,453
New +$303K 0.06% 312

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Man Investments (UK)'s MYGN Position: Q2 2014 in Review

Man Investments (UK) increased its Myriad Genetics (MYGN) stake by 11% in Q2 2014, buying an estimated $26.7K and bringing the position to 6,987 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #660.

Man Investments (UK) first reported a position in MYGN in Q2 2013 and has held it in 4 quarters since. The position peaked at $1.39M in Q3 2013. 284 funds tracked by Wall St. Rank hold MYGN as of Q2 2014.

  • Man Investments (UK) held 6,987 shares of Myriad Genetics worth $272K as of Q2 2014.
  • Man Investments (UK) bought 718 Myriad Genetics shares in Q2 2014, an estimated $26.7K.
  • Myriad Genetics made up 0.02% of Man Investments (UK)'s portfolio in Q2 2014, its #660 holding.
  • Man Investments (UK) first reported a position in Myriad Genetics in Q2 2013 and has held it in 4 quarters since.
  • Man Investments (UK)'s Myriad Genetics position peaked at $1.39M in Q3 2013.
  • 284 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2014.

Based on Man Investments (UK)'s 13F filing for Q2 2014, filed 14 Aug 2014.